2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
88
Colonic Neoplasms
30
Colonic Polyps
20
Adenoma
19
Polyps
8
Neoplasms
8
Colorectal Neoplasms, Hereditary Nonpolyposis
6
Adenomatous Polyps
6
Disease
5
Rectal Neoplasms
4
Pain
4
Gastrointestinal Neoplasms
4
Stomach Neoplasms
2
Peptic Ulcer
2
Pancreatic Neoplasms
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammatory Bowel Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Colitis, Ulcerative
2
Anus Neoplasms
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Tuberculosis
1
Triple Negative Breast Neoplasms
1
Signs and Symptoms, Digestive
1
Recurrence
1
Rectal Diseases
1
Interventions
Cyclophosphamide
9
Pemetrexed
6
pembrolizumab
5
fludarabine
5
Gemcitabine
5
Cisplatin
5
Carboplatin
5
ponatinib
4
atezolizumab
4
Rituximab
4
Dexamethasone
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
Sunitinib
3
Melphalan
3
Lutetium
3
Doxorubicin
3
Bortezomib
3
tetulomab tetraxetan lu-177
2
pralsetinib
2
pomalidomide
2
osimertinib
2
napabucasin
2
isatuximab
2
fludarabine phosphate
2
ficlatuzumab
2
entrectinib
2
entinostat
2
durvalumab
2
cobimetinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Colonoscopy
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled